New Delhi: Morepen Laboratories Limited has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate worth approximately Rs 825 crore (USD 91 million) from a leading global pharmaceutical major,…
The pact was signed for the development of Pertuzumab, indicated for HER-2 metastatic breast cancer.
The FDA expects a flood of applications for a new "plausible mechanism pathway" for approval of bespoke gene-editing treatments.
In a recent study, ticagrelor was found to be noninferior to prasugrel for a composite of ischemic events including death, myocardial infarction, stroke, and major bleeding after a year in…
Pakistan: A study published in the Journal of Clinical Gastroenterology has reported that nitazoxanide-based regimens achieve higher Helicobacter pylori eradication rates compared with standard triple therapy.Standard treatment consists of a…
Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the…
A new study published in the journal of The Lancet Neurology found that patients with Door-In–Door-Out (DIDO) times exceeding 90 minutes had lower odds of receiving endovascular therapy and higher…
UK: Children with chronic liver disease are particularly vulnerable to acute kidney injury (AKI), including hepatorenal syndrome–acute kidney injury (HRS-AKI), a severe complication associated with significant morbidity and mortality. A…
Long-term follow-up of the ASPREE randomized trial and its observational extension showed that older adults taking low-dose aspirin had a significantly higher risk of cancer-related mortality compared with placebo, while…
And other biotech news brought to you by The Readout